Quinine levels in patients with uncomplicated falciparum malaria in the Amazon region of Brazil
AUTOR(ES)
Vieira, José Luiz Fernandes, Borges, Larissa Maria Guimarães, Nascimento, Margareth Tavares Silva, Gomes, Andreza de L.S.
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2008-10
RESUMO
We examined the plasmatic concentrations of quinine in patients with uncomplicated falciparum malaria in an endemic area of the Amazon region in Brazil in a prospective clinical trial, in which a standard three-day course of oral quinine plus doxycycline was used. We measured the quinine in the plasma samples on days 0 and 3by high performance liquid chromatography. The mean concentration of quinine was 6.04 ±2.21 µg/mL in male patients and 5.98 ±1.95 µg/mL in female patients. No significant differences in quinine concentration were observed between these two groups. All samples collected before starting treatment were negative for quinine. This information could help in the development of strategies for the rational use of antimalarial drugs in Brazil.
Documentos Relacionados
- Quinine Pharmacokinetic-Pharmacodynamic Relationships in Uncomplicated Falciparum Malaria
- Adverse Effect of Rifampin on Quinine Efficacy in Uncomplicated Falciparum Malaria
- Three-Day Quinine-Clindamycin Treatment of Uncomplicated Falciparum Malaria Imported from the Tropics
- Combinations of Artemisinin and Quinine for Uncomplicated Falciparum Malaria: Efficacy and Pharmacodynamics
- Controlled Trial of 3-Day Quinine-Clindamycin Treatment versus 7-Day Quinine Treatment for Adult Travelers with Uncomplicated Falciparum Malaria Imported from the Tropics